Literature DB >> 17440355

Microscopic margins and results of surgery for dermatofibrosarcoma protuberans.

Pentscho Popov1, Tom Böhling, Sirpa Asko-Seljavaara, Erkki Tukiainen.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans is a rare low-grade sarcoma of the skin with a tendency to recur locally after inadequate excision. Treatment has traditionally been wide excision with a 2- to 3-cm gross margin. Because of the variable results presented in mainly retrospective reports, it has been queried whether local control can be as good with conventional surgery as with micrographic surgery.
METHODS: Forty patients with dermatofibrosarcoma protuberans treated by surgical excision were operated on at our center from 1987 to 2001. Data were recorded prospectively. Twenty-seven patients presented with a primary tumor and 13 with a locally recurrent tumor primarily operated on elsewhere. Gross and histologic margins were studied in detail.
RESULTS: At a mean follow-up of 40 months, there were no recurrences. Thirty-four patients required single, five patients two, and one patient three operations before the margins were adequate (mean, 1.2 stages per patient). Twenty-three patients (58 percent) needed reconstructions. Tumor-free margins were obtained in 39 patients. The average thickness of surgical gross margins was 3.1 cm; histologically defined margins averaged 1.6 cm.
CONCLUSIONS: Good local control can be achieved with wide surgery. Histologic tumor-free margins differ greatly from gross margins and are difficult to assess clinically and macroscopically. Careful postoperative histologic examination with margins measured in millimeters should be carried out to define the adequacy of excision in all directions. On average, a 1.6-cm histologic margin was adequate for complete local control. Most patients can be operated on in one stage. Reconstructions are often needed.

Entities:  

Mesh:

Year:  2007        PMID: 17440355     DOI: 10.1097/01.prs.0000246491.79337.25

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Dermatofibrosarcoma protuberans of the breast: A case study.

Authors:  Dionysios Dimas; Ioannis Boutas; Anastasios Potiris; Nektarios Koufopoulos; Dimitrios Balalis; Kyparissia Sitara; Fotios Danglis; Ioannis Misitzis
Journal:  Mol Clin Oncol       Date:  2021-01-20

2.  Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy.

Authors:  Ryan C Fields; Meera Hameed; Li-Xuan Qin; Nicole Moraco; Xiaoyu Jia; Robert G Maki; Samuel Singer; Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2010-09-16       Impact factor: 5.344

3.  Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Authors:  Ahmet Yılmaz; Erol Cenesizoglu; Ertuğrul Eğilmez; Safa Onel; Mehdi Muştu; Ahmet Cennet
Journal:  Int J Shoulder Surg       Date:  2009-01

4.  Abdominoplasty and thoraco-epigastric flaps for large anterior trunk defects after dermatofibrosarcoma protuberans wide resection: Two illustrative cases.

Authors:  Diogo Casal; Nuno Fradinho; Luísa Ramos; João Ferreira; Alice Varanda; Cláudia Diogo; José Baltazar; Mário Fernandes; Carlos Correia; Maria-Angélica Almeida
Journal:  Int J Surg Case Rep       Date:  2012-11-10

Review 5.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

6.  Dermatofibrosarcoma protuberans: A clinical analysis.

Authors:  Anqi Lyu; Qiying Wang
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

Review 7.  [Dermatofibrosarcoma protuberans, particular skin tumor: report of 32 cases and review of the literature].

Authors:  Driss Elamrani; Hatim Droussi; Samira Boukind; Keltoum Elatiqi; Meriem Dlimi; Yassine Benchamkha; Saloua Ettalbi
Journal:  Pan Afr Med J       Date:  2014-10-24

8.  Wide Local Excision for Dermatofibrosarcoma Protuberans: A Single-Center Series of 90 Patients.

Authors:  Byung Jun Kim; Hyeonwoo Kim; Ung Sik Jin; Kyung Won Minn; Hak Chang
Journal:  Biomed Res Int       Date:  2015-11-25       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.